138 related articles for article (PubMed ID: 23554032)
1. Spanish LupusPRO: cross-cultural validation study for lupus.
Jolly M; Toloza S; Block J; Mikolaitis R; Kosinski M; Wallace D; Durran-Barragan S; Bertoli A; Blazevic I; Vilá L; Cooray D; Moldovan I; Katsaros E; Weisman M; Torralba KM; Alarcón G
Lupus; 2013 Apr; 22(5):431-6. PubMed ID: 23554032
[TBL] [Abstract][Full Text] [Related]
2. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
[TBL] [Abstract][Full Text] [Related]
3. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines.
Navarra SV; Tanangunan RM; Mikolaitis-Preuss RA; Kosinski M; Block JA; Jolly M
Lupus; 2013 Mar; 22(3):262-7. PubMed ID: 23340995
[TBL] [Abstract][Full Text] [Related]
4. Turkish lupusPRO: cross-cultural validation study for lupus.
Kaya A; Goker B; Cura ES; Tezcan ME; Tufan A; Mercan R; Bitik B; Haznedaroglu S; Ozturk MA; Mikolaitis-Preuss RA; Block JA; Jolly M
Clin Rheumatol; 2014 Aug; 33(8):1079-84. PubMed ID: 23934384
[TBL] [Abstract][Full Text] [Related]
5. Hindi LupusPRO: cross cultural validation of disease specific patient reported outcome measure of lupus.
Pinto B; Jolly M; Dhooria A; Grover S; Raj JM; Devilliers H; Sharma A
Lupus; 2019 Nov; 28(13):1534-1540. PubMed ID: 31635557
[TBL] [Abstract][Full Text] [Related]
6. The French-Canadian validation of a disease-specific, patient-reported outcome measure for lupus.
Bourré-Tessier J; Clarke AE; Kosinski M; Mikolaitis-Preuss RA; Bernatsky S; Block JA; Jolly M
Lupus; 2014 Dec; 23(14):1452-9. PubMed ID: 25081500
[TBL] [Abstract][Full Text] [Related]
7. The Arabic LupusPRO: A Cross-Cultural Validation of a Disease-Specific Patient-Reported Outcome Tool for Quality of Life in Lupus Patients.
Elkaraly NE; Nasef SI; Omar AS; Fouad AM; Jolly M; Mohamed AE
Lupus; 2020 Nov; 29(13):1727-1735. PubMed ID: 32878556
[TBL] [Abstract][Full Text] [Related]
8. Disease-specific patient reported outcome tools for systemic lupus erythematosus.
Jolly M; Pickard AS; Block JA; Kumar RB; Mikolaitis RA; Wilke CT; Rodby RA; Fogg L; Sequeira W; Utset TO; Cash TF; Moldovan I; Katsaros E; Nicassio P; Ishimori ML; Kosinsky M; Merrill JT; Weisman MH; Wallace DJ
Semin Arthritis Rheum; 2012 Aug; 42(1):56-65. PubMed ID: 22480408
[TBL] [Abstract][Full Text] [Related]
9. The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.
Inoue M; Shiozawa K; Yoshihara R; Yamane T; Shima Y; Hirano T; Jolly M; Makimoto K
Lupus; 2017 Jul; 26(8):849-856. PubMed ID: 27927882
[TBL] [Abstract][Full Text] [Related]
10. Validation of the LupusPRO in Chinese patients from Hong Kong with systemic lupus erythematosus.
Mok CC; Kosinski M; Ho LY; Chan KL; Jolly M
Arthritis Care Res (Hoboken); 2015 Feb; 67(2):297-304. PubMed ID: 25156199
[TBL] [Abstract][Full Text] [Related]
11. Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus.
Azizoddin DR; Weinberg S; Gandhi N; Arora S; Block JA; Sequeira W; Jolly M
Lupus; 2018 Apr; 27(5):728-737. PubMed ID: 29087259
[TBL] [Abstract][Full Text] [Related]
12. Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus.
Han JY; Cho SK; Nam E; Kim H; Lee SS; Jolly M; Sung YK
Lupus; 2022 Oct; 31(12):1498-1507. PubMed ID: 36017605
[TBL] [Abstract][Full Text] [Related]
13. A multi-group confirmatory factor analyses of the LupusPRO between southern California and Filipino samples of patients with systemic lupus erythematosus.
Azizoddin DR; Olmstead R; Cost C; Jolly M; Ayeroff J; Racaza G; Sumner LA; Ormseth S; Weisman M; Nicassio PM
Lupus; 2017 Aug; 26(9):967-974. PubMed ID: 28059025
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of the Lupus Impact Tracker: a patient-completed tool for clinical practice to assess and monitor the impact of systemic lupus erythematosus.
Jolly M; Garris CP; Mikolaitis RA; Jhingran PM; Dennis G; Wallace DJ; Clarke A; Dooley MA; Parke A; Strand V; Alárcon GS; Kosinski M
Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1542-50. PubMed ID: 24757021
[TBL] [Abstract][Full Text] [Related]
15. Development of the Italian version of the Oswestry Disability Index (ODI-I): A cross-cultural adaptation, reliability, and validity study.
Monticone M; Baiardi P; Ferrari S; Foti C; Mugnai R; Pillastrini P; Vanti C; Zanoli G
Spine (Phila Pa 1976); 2009 Sep; 34(19):2090-5. PubMed ID: 19730216
[TBL] [Abstract][Full Text] [Related]
16. Lupus-specific health outcome measure for US patients: the LupusQoL-US version.
Jolly M; Pickard AS; Wilke C; Mikolaitis RA; Teh LS; McElhone K; Fogg L; Block J
Ann Rheum Dis; 2010 Jan; 69(1):29-33. PubMed ID: 19126561
[TBL] [Abstract][Full Text] [Related]
17. Validity and reliability of the Lupus QoL index in Turkish systemic lupus erythematosus patients.
Pamuk ON; Onat AM; Donmez S; Mengüs C; Kisacik B
Lupus; 2015 Jul; 24(8):816-21. PubMed ID: 25542903
[TBL] [Abstract][Full Text] [Related]
18. Validation in Colombia of the Oswestry disability questionnaire in patients with low back pain.
Payares K; Lugo LH; Morales V; Londoño A
Spine (Phila Pa 1976); 2011 Dec; 36(26):E1730-5. PubMed ID: 22138784
[TBL] [Abstract][Full Text] [Related]
19. Development of the Italian Version of the Neck Disability Index: cross-cultural adaptation, factor analysis, reliability, validity, and sensitivity to change.
Monticone M; Ferrante S; Vernon H; Rocca B; Dal Farra F; Foti C
Spine (Phila Pa 1976); 2012 Aug; 37(17):E1038-44. PubMed ID: 22487712
[TBL] [Abstract][Full Text] [Related]
20. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
